1. Use of fluorescence-activated vesicle sorting for isolation of Naked2-associated, basolaterally targeted exocytic vesicles for proteomics analysis. Cao Z, Li C, Higginbotham JN, Franklin JL, Tabb DL, Graves-Deal R, Hill S, Cheek K, Jerome WG, Lapierre LA, Goldenring JR, Ham AJ, Coffey RJ (2008) Mol Cell Proteomics 7(9): 1651-67
    › Primary publication · 18504258 (PubMed) · PMC2528074 (PubMed Central)
  2. TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer. Merchant NB, Voskresensky I, Rogers CM, Lafleur B, Dempsey PJ, Graves-Deal R, Revetta F, Foutch AC, Rothenberg ML, Washington MK, Coffey RJ (2008) Clin Cancer Res 14(4): 1182-91
    › Primary publication · 18281553 (PubMed) · PMC3718282 (PubMed Central)
  3. Multiple mechanisms are responsible for transactivation of the epidermal growth factor receptor in mammary epithelial cells. Rodland KD, Bollinger N, Ippolito D, Opresko LK, Coffey RJ, Zangar R, Wiley HS (2008) J Biol Chem 283(46): 31477-87
    › Primary publication · 18782770 (PubMed) · PMC2581561 (PubMed Central)
  4. Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer. Manning HC, Merchant NB, Foutch AC, Virostko JM, Wyatt SK, Shah C, McKinley ET, Xie J, Mutic NJ, Washington MK, LaFleur B, Tantawy MN, Peterson TE, Ansari MS, Baldwin RM, Rothenberg ML, Bornhop DJ, Gore JC, Coffey RJ (2008) Clin Cancer Res 14(22): 7413-22
    › Primary publication · 19010858 (PubMed) · PMC2657180 (PubMed Central)
  5. Fibrocystin/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function. Kim I, Fu Y, Hui K, Moeckel G, Mai W, Li C, Liang D, Zhao P, Ma J, Chen XZ, George AL, Coffey RJ, Feng ZP, Wu G (2008) J Am Soc Nephrol 19(3): 455-68
    › Primary publication · 18235088 (PubMed) · PMC2391052 (PubMed Central)
  6. EGF receptor-independent action of TGF-alpha protects Naked2 from AO7-mediated ubiquitylation and proteasomal degradation. Ding W, Li C, Hu T, Graves-Deal R, Fotia AB, Weissman AM, Coffey RJ (2008) Proc Natl Acad Sci U S A 105(36): 13433-8
    › Primary publication · 18757723 (PubMed) · PMC2527346 (PubMed Central)
  7. Zebrafish Naked1 and Naked2 antagonize both canonical and non-canonical Wnt signaling. Van Raay TJ, Coffey RJ, Solnica-Krezel L (2007) Dev Biol 309(2): 151-68
    › Primary publication · 17689523 (PubMed) · PMC2729589 (PubMed Central)
  8. Variability of in situ proteomic profiling and implications for study design in colorectal tumors. Li JQ, Xu BJ, Shakhtour B, Deane N, Merchant N, Heslin MJ, Washington K, Coffey RJ, Beauchamp RD, Shyr Y, Billheimer D (2007) Int J Oncol 31(1): 103-11
    › Primary publication · 17549410 (PubMed)
  9. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ, Freudenberg J, Chen X, Haigis K, Jegga AG, Kong S, Sakthivel B, Xu H, Reichling T, Azhar M, Boivin GP, Roberts RB, Bissahoyo AC, Gonzales F, Bloom GC, Eschrich S, Carter SL, Aronow JE, Kleimeyer J, Kleimeyer M, Ramaswamy V, Settle SH, Boone B, Levy S, Graff JM, Doetschman T, Groden J, Dove WF, Threadgill DW, Yeatman TJ, Coffey RJ, Aronow BJ (2007) Genome Biol 8(7): R131
    › Primary publication · 17615082 (PubMed) · PMC2323222 (PubMed Central)
  10. Targeted imaging of colonic tumors in smad3-/- mice discriminates cancer and inflammation. Deane NG, Manning HC, Foutch AC, Washington MK, Aronow BJ, Aronow BA, Bornhop DJ, Coffey RJ (2007) Mol Cancer Res 5(4): 341-9
    › Primary publication · 17426249 (PubMed)